Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation? [1]

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)123
Number of pages1
JournalJournal of Acquired Immune Deficiency Syndromes
Volume45
Issue number1
DOIs
Publication statusPublished - May 2007

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this